Factors associated with vancomycin-resistant enterococci colonization in a pediatric intensive care unit of Paraguay: A cross-sectional study on hospital charts

被引:1
|
作者
Duarte, Laura [1 ]
Arbo, Antonio [2 ]
Gallardo, Mirna [1 ]
Riquelme, Irma [1 ]
Delgadillo, Lorena [1 ]
Jimmy Jimenez, Hassel [1 ]
机构
[1] Univ Nacl Asuncion, Fac Ciencias Med, Unidad Cuidados Intens Pediat, Asuncion, Paraguay
[2] Minist Salud Publ & Bienestar Social, Inst Med Trop, Dept Pediat, Asuncion, Paraguay
来源
MEDWAVE | 2019年 / 19卷 / 08期
关键词
risk factors; vancomycin-resistant enterococcus; pediatric intensive care unit; INTESTINAL COLONIZATION; RISK-FACTORS; FAECIUM COLONIZATION; INFECTION; CARRIAGE;
D O I
10.5867/medwave.2019.08.7694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Vancomycin-resistant enterococcus (VRE) infections have become widespread and a challenge in hospitalized patients. The threat of infection by intractable enterococci and the possibility that vancomycin resistance could involve pneumococci or staphylococci advocate for careful surveillance of resistant strains. Objective To determine the risk factors associated with VRE colonization in pediatric patients admitted to the Pediatric Intensive Carc Unit (PICU) in the period between January 2012 and June 2013. Methods We conducted a cross-sectional study analyzing the clinical histories of 140 patients admitted to the PICU (children from 1 month to 18 years), who underwent rectal swab cultures within 48 hours of admission. We calculated the odds ratios and confidence intervals of the risk factors for VRE colonization in thc PICU, and then we used multiple logistic regression for the statistically significant variables. Results VRE colonization was present in 18.6% of patients. The following were identified as risk factors associated to VRE colonization: hospitalization during the previous year (odds ratio: 10.8, 95% confidence interval: 2.43 to 47.8; p = 0.001), prior use of one broad-spectrum antibiotic (odds ratio: 5.05; 95% confidence interval: 2.04 to 12.5; p = 0.000), use of two or more broad-spectrum antibiotics in the last year (odds ratio: 5.4, 95% confidence interval: 1.5 to 18.4; p = 0.009), prior hospitalization in the risk area (odds ratio: 4.91, 95% confidence interval: 1.83 to 13.2; p = 0.000), hospitalization for more than five days in high-risk area (odds ratio: 5.64, 95% confidence interval: 2.18 to 14.6; p = 0.000), and use of immunosupprcssant drugs (odds ratio: 4.84, 95% confidence interval: 1.92 to 11.9; p = 0.001). In a logistic multiple regression the use of two or more broad-spectrum antibiotics (odds ratio: 4.81, 95% confidence interval: 1.01 to 22.8; p = 0.047) and the history of prior hospitalization in the last year (odds ratio: 7.84, 95% confidence interval: 1.24 to 49.32, p = 0.028) were identified as independent factors statistically associated with VRE colonization. Conclusion Pediatric patients admitted to the Intensive Care Unit with a history of prior hospitalization in thc previous year, and exposure to two or more broad-spectrum antibiotics have a greater risk of colonization by vancomycin-resistant enterococcus.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Vancomycin-resistant Enterococcus faecium bacteremia in Spanish pediatric intensive care unit
    Soler Palacin, Pere
    Pena, Yolanda
    Pujol, Montserrat
    Bastida, Pilar
    MEDICINA CLINICA, 2007, 129 (03): : 116 - 116
  • [42] Hospital wards spreading vancomycin-resistant enterococci to intensive care units: Returning coals to Newcastle
    Farr, BM
    CRITICAL CARE MEDICINE, 1998, 26 (12) : 1942 - 1943
  • [43] Incidence and Risk Factors of Infection Caused by Vancomycin-Resistant Enterococcus Colonization in Neurosurgical Intensive Care Unit Patients
    Se, Young-Bem
    Chun, Hyoung-Joon
    Yi, Hyeong-Joong
    Kim, Dong-Won
    Ko, Yong
    Oh, Suck-Jun
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2009, 46 (02) : 123 - 129
  • [44] Risk factors associated to vancomycin-resistant enterococccus colonization in the Army Hospital in Santiago
    Braun J, Stephanie
    Fica C, Alberto
    Andrighetti B, Daniela
    Porte T, Lorena
    Triantafilo V, Vjera
    REVISTA CHILENA DE INFECTOLOGIA, 2009, 26 (04): : 374 - 375
  • [45] Active screening of vancomycin-resistant enterococci colonization and the patient outcome in a tertiary care university hospital in Japan
    Takata, T.
    Ohshiro, T.
    Hashimoto, T.
    Yoshimura, H.
    Togawa, A.
    Fujita, M.
    Watanabe, K.
    Tanaka, M.
    Muratani, T.
    Tanihara, S.
    Une, H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S108 - S108
  • [46] Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital
    Sohn, Kyung Mok
    Peck, Kyong Ran
    Joo, Eun-Jeong
    Ha, Young Eun
    Kang, Cheol-In
    Chung, Doo Ryeon
    Lee, Nam Yong
    Song, Jae-Hoon
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (04) : E240 - E246
  • [47] The characteristics and factors associated with omitted nursing care in the intensive care unit: A cross-sectional study
    Vincelette, Christian
    D'Aragon, Frederick
    Stevens, Louis-Mathieu
    Rochefort, Christian M.
    INTENSIVE AND CRITICAL CARE NURSING, 2023, 75
  • [48] Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit
    Warren, DK
    Nitin, A
    Hill, C
    Fraser, VJ
    Kollef, MH
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (02): : 99 - 104
  • [49] Mortality Predictors and Associated Factors in Patients in the Intensive Care Unit: A Cross-Sectional Study
    Soares Pinheiro, Fernanda G. de M.
    Santana Santos, Eduesley
    Barreto, Ikaro Daniel de C.
    Weiss, Carleara
    Vaez, Andreia C.
    Oliveira, Jussiely C.
    Melo, Matheus S.
    Silva, Francilene A.
    CRITICAL CARE RESEARCH AND PRACTICE, 2020, 2020
  • [50] Prevalence of colonisation with vancomycin-resistant enterococci on admission - a cross-sectional study in 6 German university hospitals, 2014
    M Wiese-Possselt
    J Zweígner
    AM Rohde
    F Schwab
    W Kern
    H Seifert
    P Gastmeier
    Antimicrobial Resistance and Infection Control, 4 (Suppl 1)